Home » News » Awards & Advancement » Biogen names Matt Griffiths as chief information officer

Biogen names Matt Griffiths as chief information officer

Thursday, May 14, 2015

Biogen has appointed Matt Griffiths as senior vice president and chief information officer. He will report to the company’s executive vice president of technology and business solutions, Adriana Karaboutis. Griffiths was promoted to the chief information officer role from his position as vice president of pharmaceutical operations and corporate information technology, having joined Biogen from Dell earlier this year.

Griffiths will develop Biogen’s overall strategy for enterprise information technology (IT), including business engagement, global solution development and support, and infrastructure, while also supporting the company’s core business and growing pipeline. Further, he will work closely with groups across Biogen’s technology and business solutions units on efforts to accelerate drug discovery and development through insights from real-world data analytics and improve patient care through the use of mobile, wearable and imaging technologies.

Previously, Griffiths spent 16 years at Dell where he held numerous IT roles in both Europe and the U.S. He was instrumental in driving new technologies and business capabilities through Dell’s manufacturing and supply chain organizations, as well as innovation in IT infrastructure.

Griffiths sits on the Pharmaceutical Information Systems Association (PISA), a nonprofit organization that shares information and IT best practices across larger biotechnology and pharmaceutical companies to further the capabilities of the industry.

Looking for more news, check out the new FREE CenterWatch Weekly!

The new FREE CenterWatch Weekly is your source of critical news, emerging trends, and business issues around everything in the rapidly changing clinical research marketplace. Check out our new CWWeekly page! Sign up today for your free email newsletter, update your bookmarks and check us out regularly! We look forward to bringing you the best news and information about clinical research in 2018!